Collegium Pharmaceutical, Inc. · NASDAQ:COLL
BlackRock, Inc. reported a 15.60% stake in Collegium Pharmaceutical, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 28, 2025
BlackRock, Inc. reported a 15.60% stake in Collegium Pharmaceutical, Inc., 4,997,827 shares, as a passive investor on Mar 31, 2025. Filed Apr 28, 2025 (Schedule 13G/A).
- Stake
- 15.60%
- Shares
- 4,997,827
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 15.60% | 4,997,827 |
Source
Related
- Collegium Pharmaceutical, Inc.
- BlackRock, Inc.
- Collegium Pharmaceutical, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G · Millennium Management LLC · Aug 24, 2026
- Schedule 13G · Fuller & Thaler Asset Management, Inc. · Aug 14, 2026
- Schedule 13G · Principal Global Investors · Aug 5, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026